Speakers
Conference Co-Chairs
Bob Go , Global Head of Life Sciences & Healthcare, Deloitte Touche Tohmatsu
Andrew Jack , Pharmaceuticals and Healthcare Correspondent, Financial Times
Speaker(s)
Carlos Alban, Senior Vice President,International Pharmaceuticals, Abbott
Jeffrey Berkowitz, SVP, Global Market Access, Merck & Co
David Brennan, Chief Executive Officer, AstraZeneca
Carolyn M Clancy MD, Director, Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services
Jérôme Contamine, Executive Vice President, Chief Financial Officer, Sanofi-Aventis
John Cowley, Chairman and Chief Executive Officer, Amicus Therapeutics
Sir Andrew Dillon CBE , Chief Executive, National Institute for Health and Clinical Excellence (NICE)
Dr Roch Doliveux, Chief Executive Officer, UCB
Eddie Gray, President, Pharmaceuticals Europe, GlaxoSmithKline
Simon Hammett, Head of Life Sciences & Healthcare, Deloitte EMEA
Rolf Hoffmann, Senior Vice President , Amgen International
Dr Erich Hunziker, Chief Financial and IT Officer, Roche
Anne Hyland, Chief Financial Officer and Company Secretary , Vectura Group plc
Rob James, Global Pharma CIO, Novartis Pharma AG
Chris Jennings, President , Jennings Policy Strategies, Inc and Former Senior Health Care Advisor to President William J. Clinton * subject to final confirmation,
Joseph Jimenez, Chief Executive Officer, Novartis
Ken Jones, Chief Operating Officer, Astellas Pharma Europe Ltd
Dr Jan Lundberg, EVP, Science and Technology and President, Lilly Research Laboratories
Dr John C Martin, Chairman & CEO, Gilead
Ann Merchant, Senior Vice President, Supply Chain, Amgen Europe
Gerry Migliaccio, Senior Vice President, Network Performance, Pfizer Global Manufacturing, Pfizer Inc
Carlo Nostaristefani, President, Technical Operations and Global Support Functions, Bristol Myers Squibb
Professor Peter Piot , Director Designate, London School of Hygiene & Tropical Medicine
Dirk Ramaekers, General Medical Director, ZNA Antwerp
Dr Joshua Sharfstein, Principal Deputy Commissioner, U.S Food and Drug Administration(FDA)
Feike Sijbesma, Chairman of the Managing Board, Royal DSM N.V * subject to final confirmation
James P Sullivan PhD, Vice President of Pharmaceuticals Discovery, Abbott
Timothy C Tyson, Chairman and CEO, Aptuit, Inc
Onno van de Stolpe, Chief Executive Officer, Galapagos
Professor Jurgen Windeler, Director, Institute for Quality and Efficiency in Healthcare (IQWiG), Germany * subject to final confirmation
